Microbial production of D-mannose and D-sedoheptulose with tunable ratios.

IF 14.9 1区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Dileep Sai Kumar Palur, Bryant Luu, Jayce E Taylor, Mohan Singhal, John Didzbalis, Justin B Siegel, Shota Atsumi
{"title":"Microbial production of D-mannose and D-sedoheptulose with tunable ratios.","authors":"Dileep Sai Kumar Palur, Bryant Luu, Jayce E Taylor, Mohan Singhal, John Didzbalis, Justin B Siegel, Shota Atsumi","doi":"10.1016/j.tibtech.2025.07.017","DOIUrl":null,"url":null,"abstract":"<p><p>Rare sugars are valuable for food and pharmaceutical applications. D-Mannose, a low-calorie sweetener, is traditionally produced via chemical extraction from plant biomass, which is unsustainable, while enzymatic methods suffer from low yields due to equilibrium limitations. Here, we demonstrate that Escherichia coli can naturally synthesize D-mannose from D-glucose through a phosphorylation-isomerization-dephosphorylation pathway. We enhanced D-mannose production by deleting competing pathways and overexpressing key biosynthetic genes. Unexpectedly, due to the promiscuous activity of the phosphatase HxpB, which dephosphorylates both D-mannose-6-phosphate (M6P) and D-sedoheptulose-7-phosphate (S7P), the engineered strain also produced D-sedoheptulose, a non-sweet rare sugar that inhibits C6 sugar consumption. Further metabolic engineering improved D-sedoheptulose production. These optimizations enabled the development of a co-production strain capable of producing both sugars with tunable ratios. By leveraging this unique sugar combination, our approach provides a sustainable route to rare sugar biosynthesis and opens new possibilities for functional food design and metabolic regulation.</p>","PeriodicalId":23324,"journal":{"name":"Trends in biotechnology","volume":" ","pages":""},"PeriodicalIF":14.9000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1016/j.tibtech.2025.07.017","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rare sugars are valuable for food and pharmaceutical applications. D-Mannose, a low-calorie sweetener, is traditionally produced via chemical extraction from plant biomass, which is unsustainable, while enzymatic methods suffer from low yields due to equilibrium limitations. Here, we demonstrate that Escherichia coli can naturally synthesize D-mannose from D-glucose through a phosphorylation-isomerization-dephosphorylation pathway. We enhanced D-mannose production by deleting competing pathways and overexpressing key biosynthetic genes. Unexpectedly, due to the promiscuous activity of the phosphatase HxpB, which dephosphorylates both D-mannose-6-phosphate (M6P) and D-sedoheptulose-7-phosphate (S7P), the engineered strain also produced D-sedoheptulose, a non-sweet rare sugar that inhibits C6 sugar consumption. Further metabolic engineering improved D-sedoheptulose production. These optimizations enabled the development of a co-production strain capable of producing both sugars with tunable ratios. By leveraging this unique sugar combination, our approach provides a sustainable route to rare sugar biosynthesis and opens new possibilities for functional food design and metabolic regulation.

可调比例d -甘露糖和d -糖庚糖的微生物生产。
稀有糖在食品和医药方面的应用很有价值。d -甘露糖是一种低热量的甜味剂,传统上是通过从植物生物质中化学提取来生产的,这是不可持续的,而酶法由于平衡限制而产量低。在这里,我们证明大肠杆菌可以通过磷酸化-异构化-去磷酸化途径自然地从d -葡萄糖合成d -甘露糖。我们通过删除竞争通路和过表达关键的生物合成基因来增强d -甘露糖的生产。出乎意料的是,由于磷酸酶HxpB的混杂活性,使d -甘露糖-6-磷酸(M6P)和D-sedoheptulose-7-磷酸(S7P)去磷酸化,工程菌株还产生了D-sedoheptulose,这是一种抑制C6糖消耗的非甜稀有糖。进一步的代谢工程提高了d - sedo庚糖的产量。这些优化使得能够以可调的比例生产两种糖的共同生产菌株的发展成为可能。通过利用这种独特的糖组合,我们的方法为稀有糖的生物合成提供了一条可持续的途径,并为功能性食品设计和代谢调节开辟了新的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Trends in biotechnology
Trends in biotechnology 工程技术-生物工程与应用微生物
CiteScore
28.60
自引率
1.20%
发文量
198
审稿时长
1 months
期刊介绍: Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences, focusing on useful science applied to, derived from, or inspired by living systems. The major themes that TIBTECH is interested in include: Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering) Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology) Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics) Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery) Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信